Presentations
"Clinical Pharmacokinetics of Cardiovascular Drugs," invited presentation, pharmacist continuing education program, Steubenville, OH, March 1973.
"Clinical Pharmacokinetics," invited presentation, pharmacist continuing education program, Columbus, OH, May 1973.
"The Influence of Bacterial Gut Hydrolysis on the Biopharmaceutics of Orally Administered Isonicotinuric Acid in Man," contributed paper, American Pharmaceutical Association Academy of Pharmaceutical Sciences, 121st A.Ph.A. Annual Meeting, New Orleans, LA, April, 1974.
"The Pharmacokinetics of Isoniazid and Some Metabolites in Man," contributed paper, American Pharmaceutical Association Academy of Pharmaceutical Sciences, 121st A.Ph.A. Annual Meeting, New Orleans, LA, April, 1974.
"Pharmacokinetics of Sulfadimethoxine in Cattle," contributed paper, American Pharmaceutical Association Academy of Pharmaceutical Sciences National Meeting, Atlanta, GA, Nov., 1975.
"Multiple Dose Pharmacokinetics of Gentamicin in Man: Adjustment of Dosage in Patients with Renal Impairment Using the Jelliffe Nomogram," invited paper, American Pharmaceutical Association Academy of Pharmaceutical Sciences, 123rd A.Ph.A. Annual Meeting, New Orleans, LA, April, 1976.
"A Modern View of Pharmacokinetics," a series of 3 invited presentations, The Columbia University Dept. of Anesthesiology Colloquia, NY, NY, Spring 1976.
"Clinical Pharmacokinetics of Benzodiazepines," invited presentation, given to a group of medical professionals at a Tucson, Arizona Hospital, June 1976.
"Biopharmaceutic and Pharmacokinetic Profile of Flunitrazepam Following Oral Administration of Single and Multiple Doses to Healthy Man," American Pharmaceutical Association Academy of Pharmaceutical Sciences National Meeting, Orlando, FL, Nov., 1976.
"Clinical Pharmacology and Pharmacokinetics of Diazepam," invited presentation, The Annual Convention of The American Association of Plastic and Reconstructive Surgeons, Beverly Hills, CA, Feb. 1977.
"Evaluation of Sustained Release Products", invited presentation, Alza Pharmaceutical Co., Palo Alto, CA, May 1977.
"Pharmacokinetics in Practice," invited presentation, Nurse Continuing Education Program, Vallejo, CA, Feb. 1978.
"Physiological and Pharmacokinetic Aspects of SustainedRelease Dosage Forms," 1st Northeastern Regional Pharmaceutical Association Meeting, Storrs, CT, Aug. 15, 1980.
"Pharmacokinetic Evaluation of Sustained Release Dosage Forms", invited presentation, USV Pharmaceutical Co., Tuckahoe, NY, Sept. 1980.
"Transfer of Drugs from Prescription to OTC Status Need for a Third Class of Drug?", invited presentation, The National Association of Boards of Pharmacy and American Association of Colleges of Pharmacy, District I Annual Meeting, Providence, RI, Oct. 35, 1980.
"Pharmacokinetics Made Simple, Parts I and II," invited presentations, Behavioral Medicine Colloquia, Veterans Administrations Medical Center, Newington, CT, Nov. 17, 1980 & Jan. 5, 1981.
"Physiological and Pharmacokinetic Aspects of Sustained Release Dosage Forms," invited presentation, The Ninth Annual Northeast Bioengineering Conference, Rutgers University, Piscataway, NJ, March 1920, 1981.
"Evolutionary Aspects of Interspecies Variations in Pharmacokinetics," contributed paper, The 2nd Annual Northeastern Regional Pharmaceutical Association Meeting, Storrs, CT, July 10, 1981.
"Interspecies Scaling, Allometry, Physiological Time and the Ground Plan of Pharmacokinetics," contributed paper, The 2nd Annual Northeastern Regional Pharmaceutical Association Meeting, Storrs, CT, July 10, 1981.
"Interspecies Variations in Pharmacokinetics: The Benzodiazepines," contributed paper, The 2nd Annual Northeastern Regional Pharmaceutical Association Meeting, Storrs, CT, July 10, 1981.
"Interspecies Variations in Pharmacokinetics: A Perspective," invited presentation, All School Seminar, The University of Connecticut School of Pharmacy, Storrs, CT, Feb. 19, 1982.
"Interspecies Variations in Pharmacokinetics: A Perspective," invited presentation, Sidney Riegelman Memorial Symposium, "Pharmacokinetics: A Modern View," San Francisco, CA, April 22 24, 1982.
"Fourth Dimensional Space and the Pharmacokinetic SpaceTime Continuum," contributed paper, The 3rd Annual Northeastern Regional Pharmaceutical Association Meeting, Danbury, CT, June 18, 1982.
"Hepatic Drug Metabolism Alterations in Disease States," invited presentation, Gastroenterology Division, University of Connecticut Health Center, Farmington, CT, Dec. 8, 1982.
"Benzodiazepine Pharmacokinetics: Clinical Highlights, Interspecies Scaling and StructureParameter Determinants," invited presentation, "Conference on the Pharmacokinetics and Pharmacodynamics of Psychoactive Drugs," National Institute of Drug Abuse, Bethesda, MD, Feb. 10, 1983.
"Alcoholism, Aging and Mortality Kinetics," contributed presentation, The Greater Hartford Pharmacokinetics Group, Hartford Hospital, Hartford, CT, May 18, 1983.
"Pharmacokinetic Determinants in the Design and Evaluation of SustainedRelease Dosage Forms,", contributed paper, The 4th Annual Northeastern Regional Pharmaceutical Association Meeting, Groton, CT, June 17, 1983.
"Interspecies Comparisons of Absorption, Distribution and Elimination of Xenobiotics: Influence of Body Size and Longevity," invited presentation, EPA sponsored Symposium, "Safer Chemicals through Molecular Design," Arlington, VA, Sept. 1115, 1983.
"Pharmacokinetics," invited presentation, Norcliff Thayer, Tarrytown, NY, Jan. 19, 1984.
"Interspecies Pharmacokinetic Scaling and Risk Assessment Models," invited presentation, Shell Toxicology Laboratory, Houston, TX, March 6, 1984.
"Interspecies Pharmacokinetic Scaling and the Evolutionary Comparative Paradigm," invited presentation, Institute for Comparative and Environmental Toxicology, Cornell University, Ithaca, NY, March 9, 1984.
"Pharmacokinetic Approaches to Interspecies Scaling," invited presentation, American Industrial Health Council Risk Assessment and Mutagenicity SubCommittee Seminar Series, Washington, D.C., March 26, 1984.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course, "Toxicology for Chemists," St. Louis, MO, April 1012, 1984.
"Interspecies Scaling and the EvolutionaryComparative Paradigm in Pharmacokinetics," invited presentation, Noontime Lecture Series of The Sigma Xi Scientific Research Society, University of Connecticut Chapter, Storrs, CT, April 24, 1984.
"Midazolam Pharmacokinetic Profile During and After Microprocessor Controlled Infusion", contributed paper, The 5th Annual Northeastern Regional Pharmaceutical Association Meeting, West Haven, CT, June 22, 1984.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course, "Toxicology for Chemists," Phila., PA, Aug. 2830, 1984.
"Interspecies Pharmacokinetic Scaling," invited presentation, Public Health Division, Amherst University, Amherst, MA, Sept. 24, 1984.
"Interspecies Pharmacokinetic Scaling and the Evolutionary Comparative Paradigm," invited presentation, Pharmacol. Dept., Oral Roberts Univ. Sch. of Medicine, Tulsa, OK, Nov. 1984.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course, "Toxicology for Chemists," Chicago, IL, Sept. 1012, 1985.
"Extrapolation of Pharmacokinetic Data from Animals to Man," invited presentation, North Jersey American Chemical Society Drug Metabolism Discussion Group Symposium, "Novel Methods for Studying Human Drug Metabolism," Somerset, NJ, Sept. 18, 1985.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course, "Toxicology for Chemists," Washington, D.C., Sept. 1820, 1985.
"Mortality Kinetics in Toxicity Studies," contributed presentation, American Pharmaceutical Association Academy of Pharmaceutical Sciences 39th National Meeting, Minneapolis, Minnesota, Oct. 2024, 1985.
"Volume Shift and Protein Leakage Corrections for the Determination of LigandProtein Binding Parameter Characterization and Free Fraction Estimates from Equilibrium Dialysis Experiments," contributed presentation, American Pharmaceutical Association Academy of Pharmaceutical Sciences 39th National Meeting, Minneapolis, Minnesota, Oct. 2024, 1985.
"Introduction to Pharmacokinetics," invited presentation, Statistical Consultants Workshop, "Pharmacokinetic Modeling," Lexington, KY, Nov. 1820, 1985.
"Introduction to Bioavailability," invited presentation, Statistical Consultants Workshop, "Bioavailability / Bioequivalence," Lexington, KY, Nov. 2122, 1985.
"Time Concepts in Physics, Biology and Pharmacokinetics," invited presentation, American Pharmaceutical Association Academy of Pharmaceutical Sciences, 133rd A.Ph.A. Annual Meeting, San Francisco, CA, March 1986.
"Introduction to Pharmacokinetics," invited presentation, Statistical Consultants Workshop, "Pharmacokinetic Modeling," Cincinnati, OH, April 1416, 1986. (April 14, 1986).
"Introduction to Bioavailability," invited presentation, Statistical Consultants Workshop, "Bioavailability / Bioequivalence," Cincinnati, OH, April 1718, 1986. (April 17, 1986)
"Interspecies Scaling in Pharmacokinetics," invited presentation, Department of Pharmaceutical Chemistry & Pharmaceutics, Duquesne University College of Pharmacy, Pittsburgh, PA, April 16, 1986.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course, "Toxicology for Chemists," N.Y., N.Y., April 1517, 1986. (April 15, 1986).
"Dynamics of Injury and Lifetable Modification in Toxicology Studies," invited presentation, Pharmaceutical Manufacturers Association Drug Metabolism Subsection Annual Meeting, Washington, D.C., Sept. 1986.
"Introduction to Pharmacokinetics," invited presentation, Statistical Consultants Workshop, "Pharmacokinetic Modeling," Lexington, KY, Oct. 68, 1986.
"Introduction to Bioavailability," invited presentation, Statistical Consultants Workshop, "Bioavailability / Bioequivalence," Lexington, KY, Nov. 1718, 1986.
"Dynamics of Injury and Lifetable Modification in Toxicology Studies," invited presentation, Harry Kostenbauder Pharmaceutical Sciences PostGraduate Research Conference, University of Kentucky College of Pharmacy, Lexington, KY, Oct. 10, 1986.
"Interspecies Pharmacokinetic Scaling," 2 invited presentations, Pharmacokinetics and Biopharmaceutics Section, University of Cincinnati College of Pharmacy, Cincinnati, OH, Oct. 17 & 24, 1986.
"Toxicokinetic DoseResponse Models of Mortality in Toxicology Studies," contributed paper, American Association of Pharmaceutical Scientists, First National Meeting, Washington, D.C., Nov., 1986.
"Publication Rates of Pharmaceutical Scientists: Application of the Waring Distribution," contributed poster, American Association of Pharmaceutical Scientists, First National Meeting, Washington, D.C., Nov., 1986.
"Influence of Kinetic and Metabolic Mechanisms on Toxicity," invited presentation, 37th Annual Meeting of The American College of Veterinary Pathologists and 21th Annual Meeting of The American Society for Veterinary Clinical Pathology, New Orleans, LA, Dec. 3, 1986.
"Interspecies Pharmacokinetic Scaling," invited presentation, Division of Pharmaceutics & Pharmaceutical Chemistry, Ohio State University College of Pharmacy, Columbus, OH, Jan. 23, 1987.
"Dynamics of Injury and Lifetable Modification in Toxicology Studies," invited presentation, Department of Pharmaceutics, University of Florida College of Pharmacy, Gainesville, FL, Jan. 26, 1987.
"The Publication Game: The Evaluator's View," invited presentation, Faculty Dinner Meeting, University of Florida College of Pharmacy, Gainesville, FL, Jan. 26, 1987.
"Dynamics of Injury and Lifetable Modification in Toxicology Studies," invited presentation, International Industrial Pharmacy Conf (presented by the College of Pharmacy and the Div of Continuing Education, The Univ of Texas at Austin), Montgomery, Texas, Feb 1519, 1987.
"Introduction to Pharmacokinetics," invited presentation, Statistical Consultants Workshop, "Pharmacokinetic Modeling," Cincinnati, OH, April 1315, 1987.
"Introduction to Bioavailability," invited presentation, Statistical Consultants Workshop, "Bioavailability / Bioequivalence," Cincinnati, OH, April 1617, 1987.
"Biopharmaceutical, Physiological and Pharmacokinetic Determinants in the Design and Evaluation of SustainedRelease Dosage Forms," invited presentation, American Association of Pharmaceutical Scientist's Midwest Regional Meeting, Chicago, Illinois, May 18, 1987.
"Interspecies Pharmacokinetic Scaling," invited presentation, The University of Toledo College of Pharmacy, Toledo, Ohio, May 27, 1987.
"Interspecies Pharmacokinetic Scaling," invited presentation, Merrell Dow Research Institute, Lepetit Research Center, Gerenzano (Varese), Italy, June 1, 1987.
"The Publication Game: Tricks and Traps," invited presentation, NATO Advanced Study Institute on Pharmacokinetics: Mathematical and Statistical Approaches to Metabolism and Distribution of Chemicals and Drugs, Erice Trapani Sicily, June 3, 1987.
"Mortality Kinetics in Toxicology Studies," invited presentation, NATO Advanced Study Institute on Pharmacokinetics: Mathematical and Statistical Approaches to Metabolism and Distribution of Chemicals and Drugs, Erice Trapani Sicily, June 11, 1987.
"Pharmacokinetic Aspects of Sustained Release Dosage Forms," invited presentation, NATO Advanced Study Institute on Pharmacokinetics: Mathematical and Statistical Approaches to Metabolism and Distribution of Chemicals and Drugs, Erice Trapani Sicily, June 11, 1987.
"Pharmacokinetic Aspects of Enterohepatic Drug Recycling," invited presentation, NATO Advanced Study Institute on Pharmacokinetics: Mathematical and Statistical Approaches to Metabolism and Distribution of Chemicals and Drugs, Erice Trapani Sicily, June 12, 1987.
"Pharmacokinetics/Toxicokinetics," invited presentation, University of Cincinnati College of Medicine Symposium "General Principles and Concepts in Toxicology and Toxicologic Pathology," Cincinnati, Ohio, July 610, 1987.
"The Reductionist and Allometric Paradigms of Interspecies Pharmacokinetic Scaling," invited presentation, 47th International Congress of Pharmaceutical Sciences of F.I.P., Amsterdam, Holland, Sept. 1, 1987.
"Dynamics of Injury and Lifetable Modification in Toxicology Studies," F. HoffmannLa Roche & Co., Basle, Switzerland, Sept. 7, 1987.
"SpaceTime Concepts and Interspecies Pharmacokinetic Scaling," invited presentation, Sandoz Ltd., Basle, Switzerland, Sept. 8, 1987.
"Interspecies Pharmacokinetic Scaling," invited presentation, Department of Mathematics, University of Queensland, St. Lucia, Australia, Nov. 11, 1987.
"Pharmacokinetic Scaling: Physiological Models, Allometry and Neoteny," invited presentation, Indianapolis/Cincinnati Discussion Group, Indianapolis, Indiana, Nov. 17, 1987.
"Gompertz Analysis of Aging, Toxicity and Hormesis," invited presentation, Pharmacokinetics and Biopharmaceutics Section, University of Cincinnati College of Pharmacy, Cincinnati, OH, Jan. 15, 1988.
"Mortality Analysis of Aging, Toxicity and LifeExtension," invited presentation, College of Pharmacy, University of Kentucky, Lexington, KY, Feb. 11, 1988.
"Interspecies Scaling of Pharmacokinetics," invited presentation, Faculty of Pharmacy, University of Toronto, Toronto, Ontario, Canada, May 10, 1988.
"Pharmacokinetic ScaleUp from Animal to Man," invited presentation, Troisiemes Journees Mediterraneennes de Pharmacocinetique, Cap d'Agde, France, May 1921, 1988.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course: "Toxicology for Chemists," Clearwater, FL, June 13, 1988.
"On pharmacokinetic Modeling," invited presentation, Harry Kostenbauder PostGraduate Research Conference, Lexington, Ky., October 1315, 1988.
"Human Serum and Plasma Protein Binding of Enoximone and its Sulfoxide Metabolite" by R.H. Hook, H. Boxenbaum, G.A. Thompson & R.A. Okerholm, contributed poster presented by H. Boxenbaum, Third Annual Meeting, American Association of Pharmaceutical Scientists, Oct. 30 Nov. 3, 1988, Orlando, Florida.
"Toxicokinetics," invited presentation, American Chemical Society Intensive Short Course: "Toxicology for Chemists," Clearwater, FL, Nov. 1618, 1988.
"Interspecies Scaling, Detoxification and Pharmacokinetics," invited presentation, Fortyfirst Annual Scientific Meeting of The Gerontological Society of America, Special Symposium Section: "Biological Basis of Human Longevity," Nov. 1822, 1988, San Francisco, Ca.
"An AgeSpecific Mortality Rate Model for Ageing, Toxicity, and Life Prolongation: Why a Little Bit of Poison May Be Good for You," invited presentation, Genentech, Inc., South San Francisco, Ca., Nov. 22, 1988.
"Drug Absorption Kinetics: Conventional Approaches," invited presentation, Pharmacokinetics and Biopharmaceutics Section, University of Cincinnati College of Pharmacy, Cincinnati, OH, Jan. 6, 1989.
"Computerized Determination of Drug Absorption Kinetics Using Lotus 123," invited presentation in collaboration with Dr. Gary A. Thompson, Pharmacokinetics and Biopharmaceutics Section, University of Cincinnati College of Pharmacy, Cincinnati, OH, Jan. 27, 1989.
"Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Feb. 2224, 1989, Charlestown, South Carolina.
"Toxicokinetics," invited presentation, American Chemical Society
Short Course: "Toxicology for Chemists," Eastman Kodak Company, Rochester, N.Y., Oct. 1012, 1989.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Eastman Kodak Company, Rochester, N.Y., Oct. 1012, 1989.
"Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, Florida, Nov. 29 Dec. 1, 1989.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, Florida, Nov. 29 Dec. 1, 1989.
"A Gompertz AgeSpecific Mortality Rate Model of Aging, Hormesis and Toxicity," invited presentation, Division of Pharmaceutics & Pharmaceutical Chemistry, Ohio State University College of Pharmacy, Columbus, OH, Jan. 3, 1990.
"Absorption, Distribution and Elimination of Benzodiazepines, with Clinical Case Studies and Applications," invited presentation, Alpha Zeta Omega (Eta Chapter) Pharmaceutical Fraternity Continuing Education Seminar, Cincinnati Jewish Hospital, May 6, 1990.
"Allometric Scaling and Drug Dosage," invited presentation, The Toxicology Forum, 1990 Annual Summer Toxicology Forum, Given Institute of Pathobiology, Aspen, Colorado, July 1620, 1990.
"Interspecies Pharmacokinetic Scaling, Biological Design and Neoteny," invited presentation, Glaxo Pharmaceuticals, Research Triangle Park, North Carolina, August 2, 1990.
"Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Washington, D.C., Aug. 21 Aug. 23, 1990.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Washington, D.C., Aug. 21 Aug. 23, 1990.
"Biphasic Mortality Response of Chipmunks in the Wild to Single Doses of Ionizing Radiation: Toxicity and Longevity Hormesis," contributed presentation, Univ. KY College of Pharmacy, Pharmaceutical Sciences PostGraduate Research Conf., Lexington, Kentucky, Oct. 46, 1990.
"Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL., Nov. 30, 1990.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL., Nov. 30, 1990.
"Drug Dosage of New Drugs of the Last Decade," invited presentation, Alpha Zeta Omega (Eta Chapter) Pharmaceutical Fraternity Continuing Education Seminar, Cincinnati Jewish Hospital, Cincinnati, OH, March 10, 1991.
"Species' Size: Biological Consequences," invited presentation, Department of Chemistry, Bucknell University, Lewisburg, PA, April 3, 1991.
"Assessing the Nature and Quality of the Hormesis Database," invited presentation, Workshop: Biological Effects of Low Level Exposures, Northeast Regional Environmental Public Health Center, School of Public Health, University of Massachusetts, Amherst, MA, April 30May 1, 1991.
"Interspecies Scaling: Mouse to Man Fact or Fiction," invited presentation, Dept. of Drug Metabolism & Pharmacokinetics, ScheringPlough Research, Bloomfield, N.J., June, 6, 1991.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Newport Beach, CA, April 79, 1992.
"Physiological Pharmacokinetic Modeling in Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Newport Beach, CA, April 79, 1992.
"Quantitative Risk Assessment," invited presentation, Allergan Pharmaceuticals, Irvine, CA, April 8, 1992.
"Toxicokinetics," invited presentation, Allergan Pharmaceuticals, Irvine, CA, April 8, 1992.
"Basic Principles of Drug Absorption and Elimination," invited presentation, Alpha Zeta Omega (Eta Chapter) Pharmaceutical Fraternity Continuing Education Seminar, Cincinnati Jewish Hospital, Cincinnati, OH, April 26, 1992.
"The Use of Interspecies Scaling in Biological Science," invited presentation, Central States Chapter: Society of Toxicology, Ninth Annual Meeting, Overland Park, Kansas, May 15, 1992.
"Interspecies Biological Scaling," invited presentation, Fall Meeting of the Mid-Atlantic College of Clinical Pharmacy, Radnor, Pennsylvania, Sept. 23, 1992.
"General Principles: Pharmacokinetics II & II," invited presentation, Basic Pharmacology Training Course, Pharmaceutical Manufacturers Association Education & Research Institute, San Francisco, CA, September 23 - October 2, 1992.
"Kinetics of Mortality: Aging, Toxicity and Paradoxical Life Prolongation (Why a Little Bit of Poison May be Good for You)," invited presentation, North Jersey ACS Drug Metabolism Discussion Group, Symposium: Issues in Drug Metabolism and Development, Somerset, N.J., October 26, 1992.
"Drug Pharmacokinetics and Joint Fluid," invited presentation, Seventh Annual Clinical Update in Rheumatology, International Symposium on Laboratory Research in Rheumatology, Symposium on the Synovial Fluid, Phila, PA, Nov. 9-12, 1992.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL, Nov. 18-20, 1992.
"Physiological Pharmacokinetic Modeling in Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL, Nov. 18-20, 1992.
"Biological Scaling," invited presentation, Temple University School of Pharmacy, Philadelphia, PA, Feb. 1, 1993.
"Clinical Pharmacology," invited presentation, Temple University School of Pharmacy, Philadelphia, PA, Feb. 1, 1993.
"General Principles: Pharmacokinetics II & II," invited presentation, Basic Pharmacology Training Course, Pharmaceutical Manufacturers Association Education & Research Institute, Phila, February 23-26, 1993.
"Mammalian Mortality Kinetics: Can Toxic Chemicals Prolong Life?" invited presentation, Philadelphia Pharmaceutical Forum, King of Prussia, PA, March 11, 1993.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Charleston, SC, March 29-31, 1993.
"Physiological Pharmacokinetic Modeling in Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Charleston, SC, March 29-31, 1993.
"First Time in Man Studies," invited presentation, Garden State/Metropolitan Chapter, American College of Clinical Pharmacology, Bedminster, NJ, May 14, 1993.
"Drug Absorption and Elimination: Relationship to Activity," invited presentation, The Second Morris Abrams Continuing Education Seminar for 1993, Philadelphia, June 13, 1993.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL, Nov. 10-11, 1993.
"Physiological Pharmacokinetic Modeling in Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL, Nov. 10-11, 1993.
"Oral Drug Delivery: Animal to Man," invited presentation, Workshop on Oral Drug Delivery: Interface between Discovery and Development, Herndon, Virginia, December 5-7, 1993.
"Problems with PBPK Modeling for Risk Assessment," invited presentation, American Chemical Society Short Course: "Pharmacokinetics and Risk Assessment," February 23-24, 1994, Washington, D.C.
"Drug Therapy Optimization," invited presentation, The First Morris Abrams Continuing Education Seminar for 1994, Alpha Zeta Omega Pharmaceutical Fraternity, Philadelphia, February 27, 1994.
"Fundamental Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Michael Mayersohn, May 1-5, 1994, Tucson, Arizona.
"Physiologic and Kinetic Aspects of Drug Absorption," invited presentation, Office of Generic Drugs, Food and Drug Administration, Rockville, MD., September 15, 1994.
"Fundamental Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Michael Mayersohn, October 10-14, 1994, Sommerst, N.J.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL, November 4, 1994.
"Physiological Pharmacokinetic Modeling in Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Clearwater, FL, November 4, 1994.
"Problems with PBPK Modeling for Risk Assessment," invited presentation, American Chemical Society Short Course: "Pharmacokinetics and Risk Assessment," February 23, 1995, Washington, D.C.
"Longevity Hormesis: Paradoxical Life Prolongation Induced by Exogenous Agents," invited presentation, Super Fund Basic Research & Education Program, Cornell University, Ithaca, NY, April 5, 1995.
"Fundamental Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Michael Mayersohn, May 7-11, 1995, Tucson, Arizona.
"Bioavailability and Bioequivalence for the Industrial Scientist: Principles, Assessment, Practical and Regulatory Issues," 4-1/2-day Intensive Course Co-Taught with Carl Metzler and Michael Mayersohn, August 12-17, 1995, Snowmass at Aspen, Colorado.
"Interspecies Scaling," invited presentation, Veterinary Division of U.S. Food and Drug Administration, Rockville, MD, October 11, 1995.
"Fundamental Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Mike Mayersohn, Oct 16-20, 1995, Somerset, NJ.
"Clinical Pharmacokinetics in Drug Development," invited presentation, The Fall Meeting of the Delaware Valley Drug Metabolism Discussion Group, November 16, 1995, Plymouth Meeting, PA.
"First Time in Human Dosage," invited presentation, BioEast >96 Conference, Jan. 15-18, 1996, Washington, D.C.
"Interspecies Pharmacokinetic Scaling," invited presentation, IBC, "International Conference on "Pharmacokinetic/Pharmacodynamic Analysis: Accelerating Drug Discovery and Development," February 1-2, 1996, Washington, D.C.
"Paradoxical Life Prolongation in Toxicology Studies," invited presentation, American Chemical Society Short Course: "Pharmacokinetics and Risk Assessment," Washington, D.C., March 19-21, 1996.
"Fundamental Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Michael Mayersohn, May 5-9, 1996, Tucson, Arizona.
"Mortality Kinetics and Paradoxical Life Prolongation: Why a Little Poison may Prolong your Life," invited presentation, Georgetown University Medical Center, Clinical Pharmacology Lecture Series, Washington, D.C., May 16, 1996.
"Quantitative Risk Assessment," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Charleston, S.C., May 29-31, 1996.
"Physiological Pharmacokinetic Modeling in Toxicokinetics," invited presentation, American Chemical Society Short Course: "Toxicology for Chemists," Charleston, S.C., May 29-31, 1996.
"Pharmacokinetics and Drug Metabolism in Drug Development: New Concept Brainstorming," invited presentation, Glaxo Wellcome, Research Triangle Park, NC, October 10, 1996.
"Interspecies Scaling in Pharmacokinetics: Application to First-Time-In-Man Studies," invited presentation, DuPont-Merck, Newark, DE, October 17, 1996.
"Newer Concepts in Pharmacokinetic and Drug Metabolism Studies in Drug Development," invited presentation, Quintiles, Inc., Research Triangle Park, NC, November 15, 1996.
"Interspecies Scaling," invited presentation, Glaxo Wellcome, Research Triangle Park, NC, November 18, 1996.
"First-Time-In-Human Studies with Emphasis on Cancer Chemotherapy," invited presentation, The Liposome Company, Princeton, NJ, January 9, 1997.
"Newer Studies in Drug Development," invited presentation, Covance Inc, Princeton, NJ, January 10, 1997.
"Interspecies Scaling in Pharmacokinetics: Opportunities and Dilemmas," invited presentation, Pfizer Central Research, Groton, CT, February 4, 1997.
"In vitro to in vivo extrapolation of microsomal and hepatocyte P-450 drug metabolism rates," invited presentation, Georgetown University Medical School, Department of Clinical Pharmacology, Washington, D.C., February 13, 1997.
"Commentary to presentations on "Dosimetry for Persistent Chemicals," invited presentation, America Industrial Health Council ILSI Risk Science Institute & Resources for the Future, Washington, D.C., April 17, 1997.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Michael Mayersohn, May 18-22, 1997, Tucson, Arizona.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2-day Intensive Course Co-Taught with Michael Mayersohn, June 9-13, 1997, Glaxo Wellcome Laboratories, Durham, NC.
"Allometric Scaling and Interspecies Pharmacokinetic Extrapolation," invited presentation, Department of Medicine, Division of Clinical Pharmacology & Medical Toxicology, Uniformed Services University of the Health Sciences, Bethesda, MD, February 19, 1998.
"Selected Topics in Pharmacokinetics for Pharmaceutical Scientists," 2-day Intensive Course Co-Taught with Michael Mayersohn, Roche Bioscience, March 2-3, 1998, Palo Alto, CA
"Selected Topics in Pharmacokinetics for Pharmaceutical Scientists," 3-day Intensive Course Co-Taught with Michael Mayersohn, Pfizer Inc., March 23-25, 1998, Groton, CT
"Mammalian Mortality Kinetics: Life Prolongation and Morbidity Reduction by Toxic Agents," invited presentation, Department of Medicine, Division of Clinical Pharmacology & Medical Toxicology, Uniformed Services University of the Health Sciences, Bethesda, MD, May 14, 1998.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, May 18-22, 1998, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 3-Day Intensive Course Co-Taught with Michael Mayersohn, DuPont Pharmaceuticals, July 6-8, 1998, Newark, DE.
"Human Cytochrome P450: In Vitro and In Vivo Studies in Drug Development," invited presentation, Office of Clinical Pharmacology and Biopharmaceutics, Food and Drug Administration, Woodmont II Building, July 23, 1998, Rockville, MD.
"Human Cytochrome P450: In Vitro and In Vivo Studies in Drug Development," invited presentation, A. R. Kamm Associates' 1998 Speaker's Program, September 24, 1998, Research Triangle Park, NC.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4 Day Intensive Course Co-Taught with Michael Mayersohn, October 12-15, 1998, Iselin, NJ.
"Allometric Principles," invited presentation. In: Short Course "Interspecies Scaling: Techniques, Concepts and Considerations," American Association of Pharmaceutical Scientist's Annual Meeting and Exposition, San Francisco, CA, November 15, 1998.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 3-Day Intensive Course Co-Taught with Michael Mayersohn, Pfizer Inc., March 16-18, 1999, Groton, CT.
"A Pharmacokinetic Perspective on the Oxidative P450 Enzyme System," invited presentation, Philadelphia Pharmaceutical Forum, April 6, 1999, Norristown, PA.
"Implications of Cytochrome P450 Metabolism for In Vitro-In Vitro Extrapolation & Pharmacokinetic Allometry: Optimization in Screening New Chemical Entities," invited presentation, Parke-Davis Company, April 28, 1999, Ann Arbor, Michigan.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, May 3-7, 1999, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 3-Day Pfizer Course Co-Taught with Michael Mayersohn, March 13-15, 2000, Groton, CT.
"Cytochrome P450 Drug Oxidation: In Vitro-In Vivo Extrapolation," invited presentation, Barnett International Conference: Drug Metabolism: Innovations in Discovery and Development, March 23-24, 2000, Philadelphia, PA.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 2-Day Schering-Plough Course, given twice consecutively, Co-Taught with Michael Mayersohn, April 3-6, 2000, Kenilworth, NJ.
"Pharmacokinetic Scale-Up: In Vitro In Vivo human and In Vivo Inter-Species Methodologies,"
invited presentation, Canadian Society for Pharmaceutical Sciences 3rd Annual Symposium, "Technology Transfer: From Bench to Market," June 8-10, 2000, Crowne Plaza Hotel Georgia, Vancouver, British Columbia, Canada.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 3-Day DuPont Pharmaceuticals Course Co-Taught with Michael Mayersohn, June 12-14, 2000, Newark, DE.
"Pharmacokinetics and Toxicokinetics for Drug Safety," Pfizer Global Research & Development, 2 Day Intensive Course, Co-Taught with Michael Mayersohn, October 16-17, 2000, Groton, CT.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Novartis Pharmaceuticals Corporation, 3 Day Intensive Course, Co-Taught with Michael Mayersohn, December 18-20, 2000, East Hanover, NJ.
"Using Controllable Factors to Reduce Overall Variability in Bioavailability/Bioequivalence Studies," Invited Presentation, Conference on "Bioavailability and Bioequivalence," Barnett International Conference Group, February 27-28, 2001, Washington, D.C.
"Drug Absorption, Newer Dosage Forms and Drug Metabolism," Invited Presentation, Pharmacy Continuing Education Program, Alpha Zeta Omega National Pharmaceutical Fraternity, Philadelphia Alumni Chapter, March 18, 2001, Philadelphia, PA.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Eisai, Inc., 2 Day Intensive Course, Co-Taught with Michael Mayersohn, March 28-29, 2001, Teaneck, NJ.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, April 23-27, 2001, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 4-Day DuPont Pharmaceuticals Course Co-Taught with Michael Mayersohn, June 18-21, 2001, Newark, DE.
"Prediction of Human Pharmacokinetic Parameters Based on In Vivo Animal Pharmacokinetics and In Vitro Human Tissue Preparation Experiments," Invited Presentation, Bayer Pharmaceuticals, July 9, 2001, West Haven, CT.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer, Inc., Groton, CT, 3 Day Intensive Course, Co-Taught with Michael Mayersohn, July 24-26, 2001, Groton, CT.
"Prediction of Human Pharmacokinetic Parameters Based on In Vivo Animal Pharmacokinetics and In Vitro Human Tissue Preparation Experiments," invited Presentation, COR Therapeutics, Inc., August 1, 2001, South San Francisco, CA.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, November 4-9, 2001, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Aventis Pharmaceuticals, Bridgewater, NJ, 2 Day Intensive Course, Co-taught with Michael Mayersohn, November 15-16, 2001.
"Inter-Drug Clinical Pharmacokinetic Considerations: Pharmacokinetic, Pharmacodynamic, Bioequivalence, Toxicokinetic and Biopharmaceutic Factors Affecting Formulation Placement," invited presentation, Barnett International Conference, "Formulary Placement of Pharmaceutical Drug Products," January 14-15, 2002, Philadelphia, PA.
"Practical Pharmacokinetics," The First Morris Abrams Continuing Education Seminar for 2002, Philadelphia Alumni Chapter, Alpha Zeta Omega National Pharmaceutical Fraternity, Sunday, March 3, 2002, The Adams Mark Hotel, Philadelphia, PA.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer, Inc., Groton, CT, 2 Day Intensive Course, Co-Taught with Michael Mayersohn, March 14-15, 2002.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Teva Pharmaceutical Co, North Wales, PA, 3 Day Intensive Course, Co-Taught with Michael Mayersohn, March 26-28, 2002.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, April 28 May 3, 2002, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer La Jolla, Del Mar, CA, 3 Day Intensive Course, Co-Taught with Michael Mayersohn, May 13-15, 2002.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer Ann Arbor, Ann Arbor, MI, 5 Days of Teaching, co-taught with Michael Mayersohn, June 24-28, 2002.
"Principles of Oral Drug Absorption," FDA Symposium on Controlled Release of Solid Oral Dosage Forms, Office of Generic Drugs Regulatory Science Training Series, Gaitheresburg, MD, September 23-24, 2002.
"Dissolution, Bioequivalence, Bioavailability: The Superiority of Absorption Rate Plots in Assessment of In Vitro Drug Absorption," Barnett International Conference "Implementing Best Practices for Dissolution, Bioequyivalence & Bioavailability to Ensure Compliance," February 3-4, 2003, Philadelphia.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, April 27-May 2, 2003.
"Selected Topics in Pharmacokinetics and Toxicokinetics for the Industrial Scientist," Pfizer Groton, Groton, CT, 3 Days of Teaching co-taught with Michael Mayersohn, June 28-30, 2003.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Cource Co-Taught with Michael Mayersohn, November 17-21, 2003, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer Ann Arbor, Ann Arbor, MI, 5 Days of Teaching co-taught with Michael Mayersohn, January 19-23, 2004.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, May 2-7, 2004, Tucson, AZ
"Selected Topics in Pharmacokinetics and Toxicokinetics," Aventis Pharmaceuticals, Bridgewater, NJ, 2 Days of Teaching co-taught with Michael Mayersohn, July 22-23, 2004.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer Inc., Groton, CT, 2 Days of Teaching co-taught with Michael Mayersohn, September 30 - October 1, 2004.
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, April 18-22, 2005, Tucson, AZ.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Pfizer Ann Arbor, Co-Taught with Michael Mayerson, May 4-5, 2005, Holiday Inn, North Campus, Ann Arbor, MI.
"Selected Topics in Pharmacokinetics and Toxicokinetics," Quest Pharmaceutical Services, Co-taught with Michael Mayersohn, June 3-4, 2005, Newark, DE
"Development of Biotechnology Prodcuts -- Biopharmaceutic and Pharmacokinetic Considerations," 3-day intensive course co-taught with Michael Mayersohn and Soo Peang Khor, August 8-12, 2005, Hilton La Jolla Torrey Pines, La Jolla, CA
"Principles of Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 day intensive course co-taught with Michael Mayersohn, November 7-11, 2005.
"Selected Topics in Pharmacokinetics and Toxicokinetics," 3-day intensive course co-taught with Michael Mayersohn, March 13-15, 2006, Novartis Institutes of Biomedical Research, Cambridge, MA
"Generic Drug Bioequivance Issues and IVIVC Challenges," Conference Speaker, Sino-American Pharmaceutical Professionas Association -- Greater Piladelphia Chapter (SAPA -- GP), April 15, 2006, Kulpsville, PA
"Selected Topics in Pharmacokinetics and Toxicokinetics," 2-day intensive course co-taught with Michael Mayersoh, April 17-18, 2006, Encysive Pharmaceuticals, Houston, TX.
"Selected topics in pharmcokinetics and toxicokinetics," 2-1/2 day intensive course co-taught with michael Mayersohn , April 24-26, 2006, Abbott Bioresearch Center, Worcester, MA
Selected Topics in Pharmacokinetics and Toxicokinetics," 2-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, April 24-26, 2006, Abbott Bioresearch Center, Worcester, MA.
"Selected Topics in Pharmacokinetics and Toxicokinetics for the Industrial Scientist," 4-1/2 Day Intensive Course Co-Taught with Michael Mayersohn, May 1-5, 2006, Tucson, AZ.
"Selected Topics in Pharmacokinetics," 3 Day Intensive Course Co-Taught with Michael Mayersohn, May 22-24, 2006, Centocor Research & Development, Radnor, PA.
